Travel Vaccines Market Report 2023-2028 | Size, Share by Companies, Growth and Analysis
IMARC Group, a leading market research company, has recently released a report titled “Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global travel vaccines market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How Big is the Travel Vaccines Market?
The global travel vaccines market size reached US$ 3.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 56.5 Billion by 2028, exhibiting a growth rate (CAGR) of 10.95% during 2023-2028.
Request For a Sample of the Report: https://www.imarcgroup.com/travel-vaccines-market/requestsample
What is Travel Vaccines?
Travel vaccines, or travel immunizations, are biologically formulated injections that are administered in an individual’s body before traveling to protect them against potentially deadly infections and diseases. These medications stimulate the immune system by creating antibodies that assist in fragmenting and defending consumers from microorganisms and pathogens. Apart from this, travel vaccinations are reliable and cost-efficient, and they prevent the occurrence of life-threatening diseases and minimize microbial invasion amongst visitors’ bodies. Consequently, mono and combination immunization travel vaccinations are strongly prescribed by healthcare professionals to an individual visiting developed or endemic countries. Currently, recommendations vary from person to person based on the tourist’s gender, age, and medical history.
What are the Growth Prospects and Trends in the Travel Vaccines Industry?
The global travel vaccines market is primarily driven by the rapid expansion in the tourism industry and the growing number of international tourist arrivals, especially during the various endemic ailments, such as COVID-19. In line with this, the increasing prevalence of multiple infectious and travel-related viruses, including hepatitis, tetanus, Japanese encephalitis, meningitis, and yellow fever, has supplemented the demand for travel vaccines. Additionally, the numerous initiatives being undertaken by regulatory authorities for mandating travel vaccination policies for tourists prior to visiting in certain disease-prone regions are favoring the market growth. Moreover, the introduction of messenger ribonucleic acid (mRNA) vaccines that correspond to the genetic sequence and help the body make necessary infection-fighting proteins is propelling the market growth. Besides this, ongoing funding in research and development (R&D) projects for creating effective vaccinations is supporting the market growth.
Buy This Report Now: https://www.imarcgroup.com/checkout?id=1155&method=265
Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.
Who are the Key Players Operating in the Travel Vaccines Market?
The report has also provided a comprehensive analysis of the competitive landscape in the global travel vaccines market. Some of the companies covered in the report include:
- GlaxoSmithKline Pharmaceuticals Limited
- Sanofi Pasteur
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- ALK-Abelló A/S
- Bavarian Nordic A/S
- Crucell (Subsidiary of Johnson & Johnson)
- CSL Limited
- AstraZeneca PLC
- Altimmune, Inc.
- Abbott Laboratories
- Hoffmann-La Roche, Inc.
What is Included in Market Segmentation?
Our report has categorized the market based on composition and disease.
Breakup by Composition:
- Mono Vaccines
- Combination Vaccines
Based on Disease:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Regional Analysis:
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others)
- Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, Others)
Ask Analyst Customized Report: https://www.imarcgroup.com/request?type=report&id=1155&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St, City: Brooklyn, State: NY, Country: United States
USA: +1-631-791-1145 | Europe & Africa: +44-702-409-7331 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com/
Follow us on twitter: @ImarcServices
LinkedIn: https://www.linkedin.com/company/imarc-group
